Hydroxychloroquine‐Induced Bradycardia in a Male Patient With Sarcoidosis: A Case Report
ABSTRACT Hydroxychloroquine (HCQ) is often used in sarcoidosis as a steroid‐sparing agent. Though generally safe, rare cardiac side effects like bradycardia can occur, especially in patients with underlying cardiac vulnerability. A 40‐year‐old South Asian male with biopsy‐proven sarcoidosis, stable...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2025-10-01
|
| סדרה: | Clinical Case Reports |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/ccr3.70986 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
